$6.89 Billion is the total value of Bellevue Group AG's 202 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 21.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IONS | Sell | IONIS PHARMACEUTICALS INC | $339,955,306 | -7.6% | 9,511,900 | -2.4% | 4.93% | +1.0% |
| ARGX | Sell | ARGENX SEsponsored adr | $330,451,634 | -4.3% | 886,928 | -2.7% | 4.80% | +4.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $264,518,226 | -20.1% | 2,613,300 | -5.8% | 3.84% | -12.7% |
| MRNA | Sell | MODERNA INC | $238,311,007 | -16.2% | 1,551,706 | -1.9% | 3.46% | -8.3% |
| INCY | Sell | INCYTE CORP | $205,282,935 | -13.6% | 2,840,500 | -3.9% | 2.98% | -5.5% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $176,962,200 | +0.1% | 3,268,000 | -2.2% | 2.57% | +9.4% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $176,932,640 | -19.2% | 883,250 | -4.1% | 2.57% | -11.6% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $172,082,137 | -4.7% | 3,439,579 | -11.9% | 2.50% | +4.2% |
| ABT | Sell | ABBOTT LABS | $166,766,714 | -9.8% | 1,646,916 | -2.2% | 2.42% | -1.4% |
| SYK | Sell | STRYKER CORPORATION | $138,388,434 | +15.0% | 484,774 | -1.5% | 2.01% | +25.7% |
| PODD | Sell | INSULET CORP | $103,213,542 | +1.4% | 323,594 | -6.4% | 1.50% | +10.9% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $102,839,514 | -11.1% | 4,747,900 | -2.2% | 1.49% | -2.8% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $92,190,095 | -19.1% | 4,013,500 | -1.1% | 1.34% | -11.5% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $92,065,731 | -22.6% | 194,811 | -13.1% | 1.34% | -15.3% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $89,122,808 | -0.8% | 646,614 | -6.7% | 1.29% | +8.5% |
| INSP | Sell | INSPIRE MED SYS INC | $88,260,307 | -12.8% | 377,068 | -6.1% | 1.28% | -4.6% |
| DXCM | Sell | DEXCOM INC | $87,725,078 | -21.6% | 755,079 | -23.6% | 1.27% | -14.3% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $86,094,546 | +8.4% | 1,040,669 | -2.2% | 1.25% | +18.5% |
| DHR | Sell | DANAHER CORPORATION | $85,036,028 | -12.5% | 337,391 | -7.9% | 1.23% | -4.4% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $83,387,175 | -30.8% | 569,857 | -24.7% | 1.21% | -24.4% |
| EXAS | Sell | EXACT SCIENCES CORP | $83,070,099 | +27.9% | 1,225,042 | -6.6% | 1.20% | +39.8% |
| HCA | Sell | HCA HEALTHCARE INC | $80,102,292 | +0.8% | 303,786 | -8.3% | 1.16% | +10.1% |
| RLAY | Sell | RELAY THERAPEUTICS INC | $68,722,722 | +9.4% | 4,172,600 | -0.8% | 1.00% | +19.5% |
| ARVN | Sell | ARVINAS INC | $58,109,640 | -21.0% | 2,127,000 | -1.1% | 0.84% | -13.6% |
| EXEL | Sell | EXELIXIS INC | $50,640,690 | +18.1% | 2,609,000 | -2.4% | 0.74% | +29.2% |
| TMDX | Sell | TRANSMEDICS GROUP INC | $47,670,823 | +13.2% | 629,484 | -7.7% | 0.69% | +23.8% |
| ANTM | Sell | ELEVANCE HEALTH INC | $42,748,535 | -44.2% | 92,970 | -37.8% | 0.62% | -39.0% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $40,697,954 | +9.8% | 899,800 | -1.3% | 0.59% | +20.1% |
| AMED | Sell | AMEDISYS INC | $39,909,406 | -22.1% | 542,616 | -11.6% | 0.58% | -14.9% |
| MOH | Sell | MOLINA HEALTHCARE INC | $38,146,481 | -37.9% | 142,609 | -23.3% | 0.55% | -32.0% |
| GMED | Sell | GLOBUS MED INCcl a | $36,682,613 | -27.4% | 647,645 | -4.8% | 0.53% | -20.6% |
| CNC | Sell | CENTENE CORP DEL | $34,723,845 | -39.0% | 549,341 | -20.8% | 0.50% | -33.2% |
| IQV | Sell | IQVIA HLDGS INC | $34,304,149 | -8.7% | 172,478 | -5.9% | 0.50% | -0.2% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $34,272,884 | +0.9% | 265,270 | -0.4% | 0.50% | +10.2% |
| HUM | Sell | HUMANA INC | $33,287,992 | -41.2% | 68,570 | -38.0% | 0.48% | -35.7% |
| PFE | Sell | PFIZER INC | $30,220,356 | -25.2% | 740,695 | -6.1% | 0.44% | -18.1% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $28,352,256 | -38.7% | 742,400 | -8.7% | 0.41% | -33.1% |
| FATE | Sell | FATE THERAPEUTICS INC | $27,677,940 | -43.6% | 4,855,779 | -0.1% | 0.40% | -38.2% |
| OMCL | Sell | OMNICELL COM | $27,185,742 | +4.0% | 463,367 | -10.6% | 0.40% | +13.8% |
| BNTX | Sell | BIONTECH SEsponsored ads | $24,475,514 | -26.3% | 196,480 | -11.1% | 0.36% | -19.5% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $21,293,791 | -21.9% | 695,421 | -0.2% | 0.31% | -14.6% |
| PHR | Sell | PHREESIA INC | $20,622,105 | -4.4% | 638,653 | -4.2% | 0.30% | +4.5% |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $17,120,200 | -12.1% | 2,140,025 | -0.6% | 0.25% | -3.9% |
| GBIO | Sell | GENERATION BIO CO | $15,567,204 | +9.2% | 3,620,280 | -0.2% | 0.23% | +19.6% |
| CI | Sell | THE CIGNA GROUP | $13,664,722 | -74.0% | 53,476 | -66.3% | 0.20% | -71.6% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $12,584,698 | +11.3% | 15,316 | -2.3% | 0.18% | +22.0% |
| BAX | Sell | BAXTER INTL INC | $11,097,784 | -32.1% | 273,614 | -14.7% | 0.16% | -25.8% |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $10,198,136 | +4.9% | 5,395,839 | -0.1% | 0.15% | +14.7% |
| AMGN | Sell | AMGEN INC | $9,275,222 | -9.3% | 38,367 | -1.5% | 0.14% | -0.7% |
| GILD | Sell | GILEAD SCIENCES INC | $8,326,537 | -25.6% | 100,356 | -23.0% | 0.12% | -18.8% |
| NVRO | Sell | NEVRO CORP | $7,901,414 | -23.5% | 218,573 | -16.2% | 0.12% | -16.1% |
| BIIB | Sell | BIOGEN INC | $6,868,453 | -12.7% | 24,704 | -13.0% | 0.10% | -3.8% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $6,691,140 | -75.2% | 4,208,264 | -2.8% | 0.10% | -72.9% |
| RDY | Sell | DR REDDYS LABS LTDadr | $5,892,255 | -8.4% | 103,500 | -17.5% | 0.09% | +1.2% |
| OLK | Sell | OLINK HLDG ABsponsored ads | $5,398,729 | -15.3% | 239,624 | -4.6% | 0.08% | -8.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $4,710,792 | -25.0% | 48,445 | -20.2% | 0.07% | -18.1% |
| MTEM | Sell | MOLECULAR TEMPLATES INC | $4,266,278 | +15.3% | 11,230,003 | -0.4% | 0.06% | +26.5% |
| LLY | Sell | LILLY ELI & CO | $3,696,573 | -8.6% | 10,764 | -2.6% | 0.05% | 0.0% |
| JNJ | Sell | JOHNSON & JOHNSON | $3,550,275 | -22.8% | 22,905 | -12.0% | 0.05% | -14.8% |
| AMWL | Sell | AMERICAN WELL CORPcl a | $3,450,740 | -37.5% | 1,462,178 | -25.1% | 0.05% | -31.5% |
| Sell | SIGHT SCIENCES INC | $2,502,122 | -30.4% | 286,284 | -2.8% | 0.04% | -25.0% | |
| GH | Sell | GUARDANT HEALTH INC | $1,926,698 | -47.7% | 82,197 | -39.3% | 0.03% | -42.9% |
| CVS | Sell | CVS HEALTH CORP | $1,695,308 | -91.1% | 22,814 | -88.8% | 0.02% | -90.1% |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $1,131,564 | -45.5% | 53,200 | -24.2% | 0.02% | -42.9% |
| MCK | Sell | MCKESSON CORP | $975,221 | -11.0% | 2,739 | -6.2% | 0.01% | -6.7% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $998,586 | -57.3% | 26,100 | -38.8% | 0.01% | -54.8% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $103,688 | -97.1% | 1,496 | -97.0% | 0.00% | -95.8% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $31,300 | -99.9% | 10,000 | -99.7% | 0.00% | -100.0% |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -14,800 | -100.0% | 0.00% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -212 | -100.0% | -0.00% | – |
| DLB | Exit | DOLBY LABORATORIES INC | $0 | – | -1,600 | -100.0% | -0.00% | – |
| ACHC | Exit | ACADIA HEALTHCARE CO IN | $0 | – | -1,287 | -100.0% | -0.00% | – |
| MKTX | Exit | MARKETAXESS HLDGS INC | $0 | – | -662 | -100.0% | -0.00% | – |
| MELI | Exit | MERCADOLIBRE INC | $0 | – | -170 | -100.0% | -0.00% | – |
| BLU | Exit | BELLUS HEALTH INC | $0 | – | -44,905 | -100.0% | -0.01% | – |
| DSGN | Exit | DESIGN THERAPEUTICS INC | $0 | – | -34,881 | -100.0% | -0.01% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -9,000 | -100.0% | -0.01% | – |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -385,014 | -100.0% | -0.01% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -7,978 | -100.0% | -0.02% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -65,864 | -100.0% | -0.02% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -12,411 | -100.0% | -0.02% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -1,622,522 | -100.0% | -0.03% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -1,290,278 | -100.0% | -0.07% | – |
| TFX | Exit | TELEFLEX INCORPORATED | $0 | – | -25,066 | -100.0% | -0.08% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -471,621 | -100.0% | -0.13% | – |
| ADPT | Exit | ADAPTIVE BIOTECHNOLOGIES COR | $0 | – | -2,960,131 | -100.0% | -0.30% | – |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -5,910,639 | -100.0% | -2.12% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BB Biotech AG #1
- Bellevue Asset Management AG #2
- Bellevue Asset Management (UK) Ltd. #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.